Dod Awards $152M Contract for Covid-19 Injector Sets to Apiject Systems America, Inc
Contract Overview
Contract Amount: $152,156,745 ($152.2M)
Contractor: Apiject Systems America, Inc.
Awarding Agency: Department of Defense
Start Date: 2020-05-08
End Date: 2023-06-30
Contract Duration: 1,148 days
Daily Burn Rate: $132.5K/day
Competition Type: NOT COMPETED
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Other
Official Description: COVID-19 DHHS, APIJECT INJECTOR SETS
Place of Performance
Location: STAMFORD, FAIRFIELD County, CONNECTICUT, 06905
Plain-Language Summary
Department of Defense obligated $152.2 million to APIJECT SYSTEMS AMERICA, INC. for work described as: COVID-19 DHHS, APIJECT INJECTOR SETS Key points: 1. Significant contract value of $152.16 million awarded. 2. Sole-source award to APIJECT SYSTEMS AMERICA, INC. raises competition concerns. 3. Contract duration of 1148 days suggests long-term need. 4. No small business participation noted in this award.
Value Assessment
Rating: questionable
The contract value of $152.16 million for injector sets is substantial. Without competitive bidding, it's difficult to assess if this price represents fair market value compared to similar products or potential alternatives.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
This contract was awarded on a sole-source basis, indicating a lack of competition. This method limits price discovery and may result in higher costs for taxpayers.
Taxpayer Impact: The absence of competition for a large contract like this could lead to inflated prices, impacting taxpayer funds negatively.
Public Impact
Ensures supply of critical medical equipment for public health initiatives. Potential for increased costs due to lack of competitive bidding. Focus on a single supplier may limit market innovation in the long run.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Sole-source award
- Lack of small business participation
- High contract value
Positive Signals
- Addresses critical need for medical supplies
Sector Analysis
The 'All Other Miscellaneous Manufacturing' sector encompasses a wide range of products. This contract for injector sets falls within this broad category, with a significant award value that may be higher than typical for this specific sub-sector without competitive benchmarking.
Small Business Impact
This contract did not include any provisions for small business participation. This represents a missed opportunity to support small businesses in the manufacturing sector and could indicate a lack of focus on broader economic impact.
Oversight & Accountability
The sole-source nature of this award warrants scrutiny to ensure the government received the best possible value and that the justification for not competing the contract was sound.
Related Government Programs
- All Other Miscellaneous Manufacturing
- Department of Defense Contracting
- Department of the Air Force Programs
Risk Flags
- Sole-source award limits competition and price discovery.
- Potential for overpayment due to lack of competitive bidding.
- No small business participation noted.
- Significant contract value requires robust oversight.
Tags
all-other-miscellaneous-manufacturing, department-of-defense, ct, definitive-contract, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $152.2 million to APIJECT SYSTEMS AMERICA, INC.. COVID-19 DHHS, APIJECT INJECTOR SETS
Who is the contractor on this award?
The obligated recipient is APIJECT SYSTEMS AMERICA, INC..
Which agency awarded this contract?
Awarding agency: Department of Defense (Department of the Air Force).
What is the total obligated amount?
The obligated amount is $152.2 million.
What is the period of performance?
Start: 2020-05-08. End: 2023-06-30.
What was the specific justification for awarding this contract on a sole-source basis, and were alternative suppliers or competitive options thoroughly explored?
The provided data indicates the contract was 'NOT COMPETED'. A full justification would typically detail why only one source was capable of meeting the requirement, such as unique capabilities, urgent need, or proprietary technology. Without this detailed justification, it's impossible to confirm if all avenues for competition were exhausted or if the sole-source decision was fully warranted.
How does the unit cost of these injector sets compare to similar products procured through competitive means, either by this agency or others?
Benchmarking the unit cost is challenging without knowing the specific technical requirements of the injector sets and comparing them to competitively procured items with similar specifications. The absence of competition for this $152 million contract makes a direct price-to-value assessment difficult. Further analysis would require detailed product specifications and market research on comparable items.
What is the long-term strategy for ensuring a competitive and cost-effective supply of these injector sets beyond the current contract's duration?
The current contract runs until June 2023. The long-term strategy is unclear from the provided data. Given the sole-source nature of this award, future procurements should prioritize competitive strategies to ensure cost savings and foster innovation within the supply chain for these critical medical devices.
Industry Classification
NAICS: Manufacturing › Other Miscellaneous Manufacturing › All Other Miscellaneous Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 2 HIGH RIDGE PARK FL 1, STAMFORD, CT, 06905
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $265,156,745
Exercised Options: $265,156,745
Current Obligation: $152,156,745
Actual Outlays: $20,628,028
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Timeline
Start Date: 2020-05-08
Current End Date: 2023-06-30
Potential End Date: 2023-06-30 00:00:00
Last Modified: 2025-04-22
More Contracts from Apiject Systems America, Inc.
- Covid-19 Injector Sets Contract Transitioning From the Dod/Af to Hhs/Aspr. Dod/Af Contract No.fa872620c0022 — $19.3M (Department of Health and Human Services)
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)